| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/11/2001 | US6287537 Radioimmunotherapy of lymphoma using anti-CD20 antibodies |
| 09/11/2001 | US6287285 Therapeutic, diagnostic, or hydrophilic coating for an intracorporeal medical device |
| 09/11/2001 | CA2208960C Hydroxyproline-rich proteins and pharmaceutical and cosmetic formulations containing them |
| 09/11/2001 | CA2176205C Osteogenic product and process |
| 09/11/2001 | CA2164866C Treatment of neuromuscular disorders and conditions with different botulinum serotype |
| 09/11/2001 | CA2125175C New peptide derivatives |
| 09/11/2001 | CA2056005C Thrombin-binding substance and process for preparing the same |
| 09/11/2001 | CA2023194C Peptides having bradykinin antagonist action |
| 09/11/2001 | CA2021528C Muteins of human erythropoietin, the preparation thereof and the use thereof |
| 09/07/2001 | WO2001064955A1 Antisense modulation of parp expression |
| 09/07/2001 | WO2001064949A2 Diagnostics and therapeutics for glaucoma |
| 09/07/2001 | WO2001064944A1 MODULATION OF PLEIOTROPHIN SIGNALING BY RECEPTOR-TYPE PROTEIN TYROSINE PHOSPHATASE β/$g(z) |
| 09/07/2001 | WO2001064937A2 Caspase-inhibitory-factor (cif) and uses thereof |
| 09/07/2001 | WO2001064922A2 Heterologous expression of neisserial proteins |
| 09/07/2001 | WO2001064920A2 Hybrid expression of neisserial proteins |
| 09/07/2001 | WO2001064918A1 Novel polypeptide---human nuclear translocator protein 12 containing atp/gtp binding domain and polynucleotide encoding it |
| 09/07/2001 | WO2001064916A1 Novel polypeptide---human excitatory amino acid transporter protein 9 and polynucleotide encoding it |
| 09/07/2001 | WO2001064915A1 Novel polypeptide---the factor 1-25 being homology with human fibroblast growth factor and polynucleotide encoding it |
| 09/07/2001 | WO2001064908A2 14790, a protein kinase and uses therefor |
| 09/07/2001 | WO2001064907A2 Lipid metabolism enzymes |
| 09/07/2001 | WO2001064906A1 Transferase 32253 and use therefor |
| 09/07/2001 | WO2001064905A2 2504, 15977, and 14760, novel protein kinase family members and uses therefor |
| 09/07/2001 | WO2001064904A2 25324, 50287, 28899, 47007, and 42967 transferase family members and uses therefor |
| 09/07/2001 | WO2001064903A2 Novel human transferase proteins and polynucleotides encoding the same |
| 09/07/2001 | WO2001064901A1 Beta 1, 2-xylosyltransferase-gene from arabidopsis |
| 09/07/2001 | WO2001064896A2 Human enzyme molecules |
| 09/07/2001 | WO2001064893A1 A novel polypeptide, a human reverse transcriptase 13 and the polynucleotide encoding the polypeptide |
| 09/07/2001 | WO2001064892A1 A NOVEL POLYPEPTIDE, A HUMAN THREONYL-tRNA SYNTHETASE 14 AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE |
| 09/07/2001 | WO2001064889A2 Tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 09/07/2001 | WO2001064887A2 32705, 23224, 27423, 32700, 32712, novel human g-proteins |
| 09/07/2001 | WO2001064885A1 Chordin-like-2 molecules and uses thereof |
| 09/07/2001 | WO2001064884A2 G12l, a gene associated with the thermal response |
| 09/07/2001 | WO2001064880A2 Human dynamin 40322 |
| 09/07/2001 | WO2001064879A2 G-proteins coupled receptor related polypeptides |
| 09/07/2001 | WO2001064877A2 Human schizophrenia gene |
| 09/07/2001 | WO2001064876A2 Human schizophrenia gene |
| 09/07/2001 | WO2001064874A2 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 09/07/2001 | WO2001064873A2 Human gtpase activator proteins |
| 09/07/2001 | WO2001064872A2 Gene 2465: methods and compositions for the diagnosis and treatment of cardiovascular, hepatic and bone disease |
| 09/07/2001 | WO2001064870A2 Mutated cyclin g1 protein |
| 09/07/2001 | WO2001064869A2 Tumor-related antigen |
| 09/07/2001 | WO2001064868A1 A novel polypeptide, a human cytokine receptor 12 and the polynucleotide encoding the polypeptide |
| 09/07/2001 | WO2001064867A1 A novel polypeptide, a human reverse transcription relative factor 33 and the polynucleotide encoding the polypeptide |
| 09/07/2001 | WO2001064866A1 A novel polypeptide, a ribosome s19e protein 11 and the polynucleotide encoding the polypeptide |
| 09/07/2001 | WO2001064856A2 Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding |
| 09/07/2001 | WO2001064855A1 Clpp |
| 09/07/2001 | WO2001064840A2 Novel bone marrow nucleic acids and polypeptides |
| 09/07/2001 | WO2001064839A2 Novel macrophage nucleic acids and polypeptides |
| 09/07/2001 | WO2001064837A2 β NETRIN AND USES THEREOF |
| 09/07/2001 | WO2001064755A2 Isoxazole gegen virale erkrankungen |
| 09/07/2001 | WO2001064752A2 Antibody inhibiting the binding between gp120 and dc-sign and screening methods |
| 09/07/2001 | WO2001064751A2 High potency recombinant antibodies and method for producing them |
| 09/07/2001 | WO2001064750A2 Modulation of the activity of the endothelial cel surface receptor ecrtp/dep-1 in the regulation of angiogenesis |
| 09/07/2001 | WO2001064747A1 Mutations in spink5 responsible for netherton's syndrome and atopic diseases |
| 09/07/2001 | WO2001064745A1 A novel polypeptide, a human beta-preprotachykinin 12 and the polynucleotide encoding the polypeptide |
| 09/07/2001 | WO2001064743A1 GPib-LIPID BOND CONSTRUCT AND USE THEREOF |
| 09/07/2001 | WO2001064742A1 Modified bdnf |
| 09/07/2001 | WO2001064741A2 Methods for selectively modulating survivin apoptosis pathways |
| 09/07/2001 | WO2001064740A1 Dna encoding squalene epoxidase promoter |
| 09/07/2001 | WO2001064738A2 Heparin-binding amino acid sequences derived from human proteins facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/07/2001 | WO2001064737A1 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 09/07/2001 | WO2001064736A2 Proliferation arrest transcription factor and its use |
| 09/07/2001 | WO2001064734A1 A novel polypeptide - human cathepsin 18 and a polynucleotide sequence encoding the same |
| 09/07/2001 | WO2001064733A1 A new polypeptide- human reverse transcription-related factor22 and the polynucleotide encoding it |
| 09/07/2001 | WO2001064731A1 A novel polypeptide, human phosphorylase kinase 18 and the polynucleotide encoding thereof |
| 09/07/2001 | WO2001064729A1 A novel polypeptide, human fd 17 and the polynucleotide encoding thereof |
| 09/07/2001 | WO2001064727A1 A novel polypeptide, mouse soluble adenylyl cyclase 25 and the polynucleotide encoding thereof |
| 09/07/2001 | WO2001064726A1 A novel polypeptide, formamidopyrimidine-dna glycosylase 37 and the polynucleotide encoding thereof |
| 09/07/2001 | WO2001064725A1 A novel polypeptide, human plasminogen activator inhibitor 2-9 and the polynucleotide encoding thereof |
| 09/07/2001 | WO2001064724A2 Maurocalcine, analogues thereof and their therapeutical uses |
| 09/07/2001 | WO2001064723A1 A novel polypeptide-homo peroxidase 8 and polynucleotide encoding said polypeptide |
| 09/07/2001 | WO2001064722A1 A novel polypeptide-homo reverse-transcription -associated protein 9 and polynucleotide encoding said polypeptide |
| 09/07/2001 | WO2001064721A1 A NOVEL POLYPEPTIDE-HUMAN ATPase 30 AND THE POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE |
| 09/07/2001 | WO2001064720A1 A novel polypeptide-homo lamin 14 and polynucleotide encoding said polypeptide |
| 09/07/2001 | WO2001064719A1 A novel polypeptide-homo negative regulator 21 of programmed cell death and polynucleotide encoding said polypeptide |
| 09/07/2001 | WO2001064717A1 Novel therapeutic treatment of chronic obstructive pulmonary disease |
| 09/07/2001 | WO2001064716A1 Antiviral compounds |
| 09/07/2001 | WO2001064714A2 Compounds and methods for modulating cell-adhesion mediated drug resistance |
| 09/07/2001 | WO2001064710A2 Sulfated ccr5 peptides for hiv-1 infection |
| 09/07/2001 | WO2001064706A1 Antisense modulation of e2f transcription factor 1 expression |
| 09/07/2001 | WO2001064703A1 Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies |
| 09/07/2001 | WO2001064692A1 Cardioprotective phosphonates and malonates |
| 09/07/2001 | WO2001064344A2 Microfabricated devices for the storage and selective exposure of chemicals and devices |
| 09/07/2001 | WO2001064258A1 Agent for the treatment of wounds |
| 09/07/2001 | WO2001064241A1 Preparations stabilized over long time |
| 09/07/2001 | WO2001064240A2 Methods for promoting production of myelin by schwann cells |
| 09/07/2001 | WO2001064239A1 A method of treatment |
| 09/07/2001 | WO2001064238A2 Methods and compositions for regulating adipocytes |
| 09/07/2001 | WO2001064236A2 METHODS FOR TREATING FSH RELATED CONDITIONS WITH GnRH ANTAGONISTS |
| 09/07/2001 | WO2001064235A1 Methods for treating, screening for, and detecting cancers expressing vascular endothelial growth factor d |
| 09/07/2001 | WO2001064234A1 Casein derived peptides and uses thereof in therapy |
| 09/07/2001 | WO2001064233A1 A method of treatment and prophylaxis |
| 09/07/2001 | WO2001064228A1 Method for producing a bioactive substance from blood serum |
| 09/07/2001 | WO2001064227A2 Androgenic activity of eucommia ulmoides extracts |
| 09/07/2001 | WO2001064188A1 Therapeutic compositions for pulmonary delivery |
| 09/07/2001 | WO2001064164A2 Nanocapsule encapsulation system and method |
| 09/07/2001 | WO2001064046A2 Method for isolating sponge collagen and producing nanoparticulate collagen, and the use thereof |
| 09/07/2001 | WO2001064031A2 Slpi knockout mice and methods for wound treatment |
| 09/07/2001 | WO2001064013A2 Methods and compositions for inhibition of membrane fusion-associated events including rsv transmission |
| 09/07/2001 | WO2001055449A8 Nucleic acids, proteins, and antibodies |